| RE50319 | Compounds and methods for treating cancer | Nov 10, 22 | Mar 04, 25 | Dana-Farber Cancer Institute, Inc. |
| RE50320 | APOE mimetic peptides and higher potency to clear plasma cholesterol | May 19, 22 | Mar 04, 25 | The UAB Research Foundation; Anji Pharmaceuticals Inc.; |
| RE50313 | Musculoskeletal stem cell and medium for inducing differentiation of musculoskeletal stem cell | Mar 02, 22 | Feb 25, 25 | CELLATOZ THERAPEUTICS, INC. |
| RE50301 | Depot systems comprising glatiramer or pharmacologically acceptable salt thereof | Aug 24, 22 | Feb 18, 25 | MAPI PHARMA LTD. |
| RE50288 | Factor IX polypeptide mutant, its uses and a method for its production | Jan 12, 23 | Feb 04, 25 | Uniqure Biopharma B.V. |
| RE50281 | Mammalian milk osteopontin for enhancing immune responsiveness | Jan 12, 22 | Jan 28, 25 | Arla Foods AMBA |
| RE50282 | Specific modification of antibody with IgG-binding peptide | Mar 11, 21 | Jan 28, 25 | Kagoshima University |
| RE50283 | Effective delivery of large genes by dual AAV vectors | Dec 03, 21 | Jan 28, 25 | FONDAZIONE TELETHON ETS |
| RE50267 | Modulators of the prostacyclin (PGI2) receptor useful for the treatment of disorders related thereto | May 18, 22 | Jan 14, 25 | Arena Pharmaceuticals Inc. |
| RE50240 | Anti-human transferrin receptor antibody capable of penetrating blood-brain barrier | Jan 29, 21 | Dec 24, 24 | JCR Pharmaceuticals Co. Ltd. |
| RE50230 | Method of treatment of hypoxia inducible factor (HIF)-related conditions | May 25, 22 | Dec 10, 24 | GRIFOLS WORLDWIDE OPERATIONS LIMITED |
| RE50218 | Non-steroidal anti-inflammatory ophthalmic compositions | Apr 22, 22 | Nov 26, 24 | SUN PHARMACEUTICAL INDUSTRIES LIMITED |
| RE50189 | Long term treatment of HIV-infection with TMC278 | Sep 13, 21 | Oct 29, 24 | Janssen Sciences Ireland Unlimited Company |
| RE50096 | Nanoemulsion compositions of taxoid drugs, and methods for the use thereof to target cancer cells and cancer stem cells | Feb 19, 21 | Aug 27, 24 | The Research Foundation for the State University New York; TargaGenix, Inc.; Northeastern University; |
| RE50060 | Topical administration method | Aug 31, 22 | Jul 30, 24 | Novaliq GmbH |
| RE50049 | Compositions and methods for treating psoriasis | Jun 28, 21 | Jul 23, 24 | Sytheon Ltd |
| RE50050 | Pyrimidinedione compounds | Mar 19, 22 | Jul 23, 24 | MyoKardia, Inc. |
| RE50040 | Atropine pharmaceutical compositions | Mar 02, 22 | Jul 16, 24 | VYLUMA INC. |
| RE50030 | Methods to treat lymphoplasmacytic lymphoma | Nov 24, 21 | Jul 02, 24 | Dana-Farber Cancer Institute, Inc. |
| RE49985 | Electrostatic printing of cyclodextrin compositions | Aug 12, 21 | May 28, 24 | Verdant Technologies, LLC |